Retigabine add-on for refractory partial-onset seizures

To evaluate the efficacy and tolerability of retigabine as an add-on therapy for people with refractory partial onset seizures.

This is a protocol.

You may also be interested in:

Talampanel as add-on therapy for the treatment of refractory partial epilepsy
Rufinamide add-on therapy for refractory epilepsy
Vigabatrin for refractory partial epilepsy
Progabide add-on for refractory epilepsy
Felbamate used with other antiepileptic drugs for drug-resistant focal epilepsy

Health topics:

Neurology > Epilepsy > Drugs for broad populations

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.